BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12692062)

  • 1. Results of national registration of familial adenomatous polyposis.
    Bülow S
    Gut; 2003 May; 52(5):742-6. PubMed ID: 12692062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register.
    Bülow S; Bülow C; Nielsen TF; Karlsen L; Moesgaard F
    Scand J Gastroenterol; 1995 Oct; 30(10):989-93. PubMed ID: 8545620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register.
    Bülow S; Faurschou Nielsen T; Bülow C; Bisgaard ML; Karlsen L; Moesgaard F
    Int J Colorectal Dis; 1996; 11(2):88-91. PubMed ID: 8739833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognosis in familial adenomatous polyposis. Results from the Polyposis Registry].
    Bülow C; Bülow S; Nielsen TF; Karlsen L; Moesgaard FA
    Ugeskr Laeger; 1996 Jul; 158(29):4188-90. PubMed ID: 8701535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal Cancer in Individuals With Familial Adenomatous Polyposis, Based on Analysis of the Danish Polyposis Registry.
    Karstensen JG; Burisch J; Pommergaard HC; Aalling L; Højen H; Jespersen N; Schmidt PN; Bülow S
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2294-2300.e1. PubMed ID: 30743005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival.
    Järvinen HJ
    Gut; 1992 Mar; 33(3):357-60. PubMed ID: 1314763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Familial adenomatous polyposis. Results from the Polyposis Registry through 25 years].
    Bülow S
    Ugeskr Laeger; 2004 Aug; 166(32):2668-70. PubMed ID: 15347170
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis.
    Mallinson EK; Newton KF; Bowen J; Lalloo F; Clancy T; Hill J; Evans DG
    Gut; 2010 Oct; 59(10):1378-82. PubMed ID: 20660077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of screening examinations on survival in familial adenomatous polyposis.
    Heiskanen I; Luostarinen T; Järvinen HJ
    Scand J Gastroenterol; 2000 Dec; 35(12):1284-7. PubMed ID: 11199368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of a registry on survival in familial adenomatous polyposis].
    Reyes Moreno J; Ginard Vicens D; Vanrell M; Mariñó Z; Garau I; Llompart A; Obrador Adrover A
    Med Clin (Barc); 2007 Jun; 129(2):51-2. PubMed ID: 17588361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes of death in familial adenomatous polyposis.
    Galle TS; Juel K; Bülow S
    Scand J Gastroenterol; 1999 Aug; 34(8):808-12. PubMed ID: 10499482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer in Patients With Familial Adenomatous Polyposis: A Nationwide Danish Cohort Study With Matched Controls.
    Karstensen JG; Bülow S; Højen H; Jelsig AM; Jespersen N; Andersen KK; Wewer MD; Burisch J; Pommergaard HC
    Gastroenterology; 2023 Sep; 165(3):573-581.e3. PubMed ID: 37201686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uses of a familial adenomatous polyposis registry.
    Dalpatadu KU; Anwar N; Wijesuriya SR; Kumarage SK; Amarasinghe B; Deen KI
    Ceylon Med J; 2011 Jun; 56(2):66-9. PubMed ID: 21789868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females.
    Björk J; Akerbrant H; Iselius L; Alm T; Hultcrantz R
    Scand J Gastroenterol; 1999 Dec; 34(12):1230-5. PubMed ID: 10636071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the age and the development of colorectal cancer in patients with familial adenomatous polyposis: a multi-institutional study.
    Kobayashi H; Ishida H; Ueno H; Hinoi T; Inoue Y; Ishida F; Kanemitsu Y; Konishi T; Yamaguchi T; Tomita N; Matsubara N; Watanabe T; Sugihara K
    Surg Today; 2017 Apr; 47(4):470-475. PubMed ID: 27506752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer: no longer the issue in familial adenomatous polyposis?
    Gibbons DC; Sinha A; Phillips RK; Clark SK
    Fam Cancer; 2011 Mar; 10(1):11-20. PubMed ID: 21052851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan.
    Iwama T; Tamura K; Morita T; Hirai T; Hasegawa H; Koizumi K; Shirouzu K; Sugihara K; Yamamura T; Muto T; Utsunomiya J;
    Int J Clin Oncol; 2004 Aug; 9(4):308-16. PubMed ID: 15375708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Screening on Survival in Familial Adenomatous Polyposis.
    Koskenvuo L; Pitkäniemi J; Rantanen M; Lepistö A
    J Clin Gastroenterol; 2016 Jan; 50(1):40-4. PubMed ID: 26485107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate.
    Bisgaard ML; Fenger K; Bülow S; Niebuhr E; Mohr J
    Hum Mutat; 1994; 3(2):121-5. PubMed ID: 8199592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approaches for patients with coexisting familial adenomatous polyposis and colorectal cancer.
    Inoue Y; Ishida H; Ueno H; Kobayashi H; Yamaguchi T; Konishi T; Tomita N; Matsubara N; Ishida F; Hinoi T; Kanemitsu Y; Watanabe T; Sugihara K
    Jpn J Clin Oncol; 2016 Sep; 46(9):819-24. PubMed ID: 27418167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.